糖尿病中便秘与血糖控制不良和糖尿病并发症有关:目前的状况和未来的方向
概括
糖尿病便秘是一种常见的并发症,由未知的原因引起,影响肠道结构和功能. 了解这些机制是开发糖尿病肠道疾病新疗法的关键.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 糖尿病学 糖尿病学
背景情况:
- 便秘是糖尿病的一个常见并发症.
- 糖尿病的流行和人口老龄化增加了糖尿病患者对胃肠道功能障碍的兴趣.
- 尽管在高血糖管理方面取得了进展,但糖尿病便秘的特定致病性仍然不清楚.
研究的目的:
- 审查糖尿病和便秘之间的复杂关系.
- 探索肠道的形态和生物力学变化.
- 检查肠道神经元,信号通路和氧化应激的变化.
主要方法:
- 关于糖尿病和便秘的研究的文献综述.
- 对糖尿病肠道的形态和生物力学变化的分析.
- 研究神经元,细胞信号和氧化应激通路.
主要成果:
- 糖尿病严重影响胃肠道的功能和结构.
- 肠道运动功能障碍与形态和生物力学重塑有关.
- 肠道神经元,细胞信号和氧化应激的变化有助于糖尿病便秘.
结论:
- 糖尿病便秘的发病过程涉及复杂的相互作用.
- 需要对新型目标进行进一步的研究.
- 这些研究可能会产生糖尿病便秘的新疗法策略.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
307
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
923
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
595
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
595
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Assessment of the Rectum and Anus
278
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
278
Diabetes: Management and Pharmacotherapy
317
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
317
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
208
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
208
